Analytical Data
-
基因名
SLMAP
- Application
-
别名
SLMAP; KIAA1601; SLAP; UNQ1847/PRO3577; Sarcolemmal membrane-associated protein; Sarcolemmal-associated protein
-
种属
Human
-
表达系统
E. coli
-
标签
GST-tag at N-terminal
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q14BN4
-
表达区间
677-784 aa
-
氨基酸序列
LHNSQKQSLELTSDLSILQMSRKELENQVGSLKEQHLRDSADLKTLLSKAENQAKDVQKEYEKTQTVLSELKLKFEMTEQEKQSITDELKQCKNNLKLLREKGNNKPW
-
分子量
37.62 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
SLMAP (Skeletal Muscle and Heart-specific Lymphocyte Antigen 1) is a protein that has garnered attention in recent years due to its potential roles in muscle biology and its implications in various cardiovascular diseases. Originally identified in skeletal muscle and heart tissues, SLMAP is involved in muscle development and regeneration, as well as the maintenance of cardiac function. The research background surrounding SLMAP highlights its significance as a member of the muscle-specific protein family, which affects myofibril organization and cellular signaling pathways. Studies have suggested that alterations in SLMAP expression may be linked to conditions such as muscular dystrophy, heart failure, and other myopathies. Given the rising prevalence of such disorders globally, understanding the molecular mechanisms governed by SLMAP could pave the way for novel therapeutic strategies. Recent advancements in recombinant protein technology have facilitated detailed investigations of SLMAP’s structure and function, enabling researchers to study its interactions with other cellular components and to elucidate its role in disease pathogenesis. As a result, SLMAP is not only a crucial biomarker for muscle and heart health but also a promising target for drug development and regenerative medicine.
